| Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets S Khan, S Shukla, S Sinha, SM Meeran Cytokine & growth factor reviews 24 (6), 503-513, 2013 | 185 | 2013 |
| Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches A Sharma, J Vora, D Patel, S Sinha, PC Jha, N Shrivastava Journal of Biomolecular Structure and Dynamics 40 (7), 3296-3311, 2022 | 87 | 2022 |
| Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis S Shukla, S Sinha, S Khan, S Kumar, K Singh, K Mitra, R Maurya, ... Scientific reports 6 (1), 21860, 2016 | 72 | 2016 |
| Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis S Sinha, S Khan, S Shukla, AD Lakra, S Kumar, G Das, R Maurya, ... The international journal of biochemistry & cell biology 77, 41-56, 2016 | 65 | 2016 |
| Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds J Vora, S Patel, M Athar, S Sinha, MT Chhabria, PC Jha, N Shrivastava Journal of Biomolecular Structure and Dynamics, 2019 | 64 | 2019 |
| Centchroman suppresses breast cancer metastasis by reversing epithelial–mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling S Khan, S Shukla, S Sinha, AD Lakra, HK Bora, SM Meeran The International Journal of Biochemistry & Cell Biology 58, 1-16, 2015 | 60 | 2015 |
| Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis S Shukla, S Khan, S Kumar, S Sinha, M Farhan, HK Bora, R Maurya, ... Cancer prevention research 8 (6), 552-562, 2015 | 56 | 2015 |
| Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV J Vora, S Patel, S Sinha, S Sharma, A Srivastava, M Chhabria, ... Journal of Biomolecular Structure and Dynamics 37 (1), 131-146, 2019 | 52 | 2019 |
| Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells S Sinha, S Shukla, S Khan, TO Tollefsbol, SM Meeran Molecular and cellular endocrinology 406, 102-114, 2015 | 50 | 2015 |
| Therapeutic targeting hypoxia-inducible factor (HIF-1) in cancer: cutting gordian knot of cancer cell metabolism A Sharma, S Sinha, N Shrivastava Frontiers in genetics 13, 849040, 2022 | 43 | 2022 |
| Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya J Vora, S Patel, S Sinha, S Sharma, A Srivastava, M Chhabria, ... Journal of Biomolecular Structure and Dynamics, 2018 | 29 | 2018 |
| Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling S Sinha, S Sharma, J Vora, H Shah, A Srivastava, N Shrivastava Journal of ethnopharmacology 217, 23-35, 2018 | 27 | 2018 |
| Epigenetic targets in cancer and aging: dietary and therapeutic interventions S Khan, S Shukla, S Sinha, SM Meeran Expert opinion on therapeutic targets 20 (6), 689-703, 2016 | 26 | 2016 |
| Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study S Sinha, S Patel, M Athar, J Vora, MT Chhabria, PC Jha, N Shrivastava International journal of biological macromolecules 140, 454-468, 2019 | 23 | 2019 |
| Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis S Khan, S Shukla, M Farhan, S Sinha, AD Lakra, D Penta, A Kannan, ... Life Sciences 256, 117976, 2020 | 20 | 2020 |
| Telomeric repeat containing RNA (TERRA): aging and cancer S Sinha, S Shukla, S Khan, M Farhan, MA Kamal, S Musthapa Meeran CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015 | 20 | 2015 |
| Emerging role of sirtuins in breast cancer metastasis and multidrug resistance: Implication for novel therapeutic strategies targeting sirtuins S Sinha, S Sharma, J Vora, N Shrivastava Pharmacological Research 158, 104880, 2020 | 18 | 2020 |
| Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis A Sharma, D Yadav, P Rao, S Sinha, D Goswami, RM Rawal, ... Computers in Biology and Medicine 146, 105688, 2022 | 17 | 2022 |
| Lung cancer stem cells: an epigenetic perspective S Shukla, S Khan, S Sinha, SM Meeran Current cancer drug targets 18 (1), 16-31, 2018 | 14 | 2018 |
| Kaempferol and Apigenin suppresses the stemness properties of TNBC cells by modulating Sirtuins A Sharma, S Sinha, H Keswani, N Shrivastava Molecular Diversity 26 (6), 3225-3240, 2022 | 12 | 2022 |
Syed Musthapa MeeranSenior Principal Scientist & Professor, Department of Biochemistry, CSIR-CFTRIVerified email at cftri.res.in
